Molecular Diagnostics
Gene Expression Profiling of Mucinous Ovarian Tumors Identifies Prognosis Markers
Advanced stage mucinous ovarian tumors have poor chemotherapy response and prognosis and lack biomarkers to aid Stage I adjuvant treatment. Differentiating primary mucinous ovarian carcinoma (MOC) from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. More...18 Oct 2022
Link Identified Between Mitochondria and Pancreatic Cancer Risk
Tumors invariably rewire their metabolism to promote cellular plasticity, adapt to ever-changing nutrient availability and acquire traits of aggressive disease, including metastatic competence. Cancer metabolism has long been equated with the preferential utilization of glycolysis by tumor cells even when oxygen is present. More...18 Oct 2022
Nucleic Acid Amplification Technology to Help Develop Instrument-Free Assays
A new ambient amplification method could introduce an unprecedented robustness into molecular detection assays because it enables maximum amplification without heat-activation and in a range of temperatures, opening up various opportunities for point-of-need testing in different temperature and geographical settings. More...18 Oct 2022
Fecal Immunochemical Test a Less Expensive Alternative for Colorectal Cancer Screening
A new study has revealed that a fecal immunochemical test (FIT) costs about one-fifth of a multi-target stool DNA test. These results align with previous studies out of Japan and the Netherlands examining FIT as an appropriate screening modality that is more cost effective than other types of noninvasive colorectal screening tests. More...
18 Oct 2022
Direct-From-Blood Molecular Diagnostic Test to Rapidly Detect Early Lyme Disease
A sensitive diagnostic test that identifies Borrelia burgdorferi directly from a patient’s blood could provide greater accuracy in the diagnosis of early Lyme disease, which may help improve care and lead to better patient outcomes. More...17 Oct 2022
Oncology Test Integration with EMR to Simplify MRD Testing Workflows
The integration of the only FDA-cleared test that can monitor minimal residual disease (MRD) in patients suffering from blood cancers with the most widely used comprehensive electronic health record (EHR) will streamline clinical decision-making for oncologists. More...14 Oct 2022
 assay.jpg)
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Rapid Molecular Testing Device
FlashDetect Flash10
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
In Other News
New Testing Method Simplifies Tuberculosis Diagnosis
Rapid Blood Test Predicts Organ Transplant Rejection in Six Hours
Levels of Circulating Cell-Free DNA Predict Risk of Developing Dementia
Molecular IVD Assay Identifies Women at High Risk for Cervical Cancer
Rapid Diagnostic Tool to Revolutionize Diagnosis of Tick-Borne Diseases
Fragile X Syndrome Mutations Found With Comprehensive Testing Method
Genetic Prognosis Explored for Pediatric Dilated Cardiomyopathy
Highly Sensitive Biosensing Technology Diagnoses Alzheimer’s Disease in Blood
A Novel Gene Signature Predicts Likelihood of Neuroblastoma Relapse
State-Of-The-Art POC Molecular System to Allow Untrained Operators to Perform Testing for Viral and Bacterial Pathogens
Blood Test to Screen for Fungus May Offer Brand-New Method for Early Cancer Detection
Molecular Test Accurately Classifies Pancreatic Cysts as Potentially Cancerous or Benign
New Insights into Molecular Interactions Pave Way for Rapid AKI Diagnostic Tests
Next-Gen Ebola Test to Offer Improved Sensitivity and More Automation
Troponin Testing Could Improve Timing of Heart Surgery and Survival Rate
Simple Blood Draw Could Revolutionize Early Breast Cancer Detection
Liquid Biopsy Testing Platform Offers Unprecedented Sensitivity for MRD Detection
New Avenues for Use of Single-Molecule Detection Assays in Clinical Diagnosis
Single Blood Test Enables Early Detection of Multiple Cancer Types
World's First Sensitive and Specific Diagnostic Test to Diagnose Acute Rheumatic Fever
Novel Biomarker Predicts Response to Therapy in Patients with a Rare Form of Metastatic Colorectal Cancer
CDH1 Overexpression Predicts Early-Stage Bladder Cancer
Biosensor Detects Brain Tumors with Less Than a Drop of Blood
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
